GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asiatic Laboratories Ltd (DHA:ASIATICLAB) » Definitions » LT-Debt-to-Total-Asset

Asiatic Laboratories (DHA:ASIATICLAB) LT-Debt-to-Total-Asset : 0.00 (As of . 20)


View and export this data going back to 2024. Start your Free Trial

What is Asiatic Laboratories LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Asiatic Laboratories's long-term debt to total assests ratio for the quarter that ended in . 20 was 0.00.

Asiatic Laboratories's long-term debt to total assets ratio stayed the same from . 20 (0.00) to . 20 (0.00).


Asiatic Laboratories LT-Debt-to-Total-Asset Historical Data

The historical data trend for Asiatic Laboratories's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asiatic Laboratories LT-Debt-to-Total-Asset Chart

Asiatic Laboratories Annual Data
Trend
LT-Debt-to-Total-Asset

Asiatic Laboratories Semi-Annual Data
LT-Debt-to-Total-Asset

Asiatic Laboratories LT-Debt-to-Total-Asset Calculation

Asiatic Laboratories's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in . 20 is calculated as

LT Debt to Total Assets (A: . 20 )=Long-Term Debt & Capital Lease Obligation (A: . 20 )/Total Assets (A: . 20 )
=/
=

Asiatic Laboratories's Long-Term Debt to Total Asset Ratio for the quarter that ended in . 20 is calculated as

LT Debt to Total Assets (Q: . 20 )=Long-Term Debt & Capital Lease Obligation (Q: . 20 )/Total Assets (Q: . 20 )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asiatic Laboratories  (DHA:ASIATICLAB) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Asiatic Laboratories LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Asiatic Laboratories's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Asiatic Laboratories (DHA:ASIATICLAB) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Siddeshwari Circular Road, 42-43, Treasure Island (5 th Floor) Shantinagar, Dhaka, BGD, 1217
Asiatic Laboratories Ltd is engaged in manufacturing and marketing of a wide range of the rapeutical medicines pharmaceutical products in the categories of Biological, Non-Biological & Sterile Pharmaceutical dosage. It has 80 generic molecules comprising therapeutic classes like antibiotics, antihistamines, bronchodilators, vitamins-minerals, antiulcerants, laxatives, gastroprokinetics, antihematinic, anthelmentics, CNS drugs, respiratory drugs, NSAIDs, dermatological preparations and sterile ophthalmic preparations.

Asiatic Laboratories (DHA:ASIATICLAB) Headlines

No Headlines